글로벌 알렉시파믹 약물 시장 – 2029년까지의 산업 동향 및 예측

알렉시파믹 약물 시장 분석 및 규모

글로벌 알렉시파믹 약물 시장은 예측 기간 동안 엄청난 성장을 보일 것으로 예상됩니다. 알렉시파믹 약물 시장의 성장은 정신 활성 물질 남용 사례가 증가하고 마약 약물에 대한 의존도가 증가함에 따라 가속화됩니다. 반대로, 대체 치료법과 새로운 경쟁 약물의 출시는 알렉시파믹 약물 시장의 성장을 방해합니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 알렉시파믹 약물 시장의 성장률을 분석합니다. 글로벌 알렉시파믹 약물 시장의 예상 CAGR은 언급된 예측 기간 동안 약 5%인 경향이 있습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

알렉시파마 약물은 일반적으로 해독제로 사용되는 치료제로, 사람이 의도적으로 또는 실수로 섭취한 독의 원치 않는 효과와 독성 효과를 중화하거나 길항합니다. 많은 알렉시파마 약물은 독성 대사산물의 형성을 막거나 수용체 결합 부위에서 독성 물질의 효과를 억제하여 작용합니다.

알렉시파믹 약물 시장 범위 및 세분화

Global Alexipharmic Drugs Market Dynamics

Drivers

• Prevalence of Chronic Diseases

In 2018, around 51.8% of U.S. adults had at least one chronic condition, and around 27.2% had multiple chronic conditions. The prevalence was seen to be highest among women, adults aged 65 or older, and those living in rural areas. Thus, it boosts market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Rising Adoption of Alcohol Consumption

According to the 2019 National Survey on Drug Use and Health (NSDUH), approximately 85.6 percent of people aged 18 years and above reported drinking alcohol at some point in their lifetime. In addition to this, the sedentary lifestyle and increasing stress compel the people for more consumption. Thus, all these factors enhance the market expansion.

• Increasing Demand for Retail Pharmacies

Rise in the number of renal drugs being delivered through retail pharmacies and surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Side Effects of alexipharmic drugs

The side effects associated with these drugs could curb the growth of the global alexipharmic drugs market over a forecast period. Excessive use of such drugs can lead to rashes, sleeplessness, vomiting, nausea, and several others, can hamper the market growth.

• High Cost

The huge expenditure associated with these agents surely hamper the market growth.

This global alexipharmic drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global alexipharmic drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Alexipharmic Drugs Market            

COVID-19 left a major impact on the global alexipharmic drugs market and even in the post pandemic situation, the market is expected to grow. Healthcare professionals had a huge responsibility to treat COVID-19 patients, which created a shift towards treating these chronic patients. This resulted in a shift in treating COVID-19 patients, thus boosting the market growth.

Global Alexipharmic Drugs Market Scope

The global alexipharmic drugs market is segmented on the basis of indication, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

• Alcoholic Overdose
• Opioid Overdose
• Cyanide Poisoning
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Alexipharmic Drugs Market Regional Analysis/Insights

The global alexipharmic drugs market is analysed and market size insights and trends are provided by indication, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global alexipharmic drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a highest growth for global alexipharmic drugs market throughout the forecasted period due to the presence of refined healthcare infrastructure and large availability of treatment options.

North America dominates the market due to high incidence of poison cases and rise in research and development activities for alexipharmic drugs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Alexipharmic Drugs Market Share Analysis

글로벌 알렉시파믹 약물 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 글로벌 알렉시파믹 약물 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 알렉시파믹 약물 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 파이저 주식회사(미국)
• 아스트라제네카(영국)
• 브리스톨-마이어스 스퀴브 회사(미국)
• Teva Pharmaceutical Industries Ltd(이스라엘)
• Sun Pharmaceutical Industries Ltd(인도)
• 마일런 NV(미국)
• 노바티스 AG(스위스)
• 루팡(인도)
• Cipla Inc(인도)
• Aurobindo Pharma(인도)
• Fresenius SE & Co. KGaA(독일)
• 사노피(프랑스)
• F. 호프만-라 로슈 유한회사(스위스)
• 애벗(미국)
• Bausch Health Companies Inc. (캐나다)
• Hope Pharmaceuticals (미국)

SKU-53988